Sign in

CIK 0001770787

  • Large accelerated filer

10x Genomics, Inc.

Sign in to watch
Ticker
TXG
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455614458
Phone
+1 925-401-7300
Business address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
  1. 4 Grant or award Director acquired 8,829 shares (grant or award)
  2. 4 Grant or award Director acquired 8,829 shares (grant or award)
  3. 4 Grant or award Director acquired 8,829 shares (grant or award)
  4. 4 Grant or award Director acquired 8,829 shares (grant or award)
  5. 4 Planned sale Chief Executive Officer sold 28,893 shares at an average $24.54 ($709,057)
  6. 4 Open-market sale Hindson Benjamin J. sold 11,595 shares at $24.44 ($283,399)
  7. 4 Open-market sale Chief Financial Officer sold 15,098 shares at $24.44 ($369,018)
  8. 4 Planned sale Chief Executive Officer sold 5,000 shares at $24.56 ($122,784)
  9. 4 Planned sale Chief Executive Officer sold 15,000 shares at an average $19.26 ($288,909)
  10. 4 Planned sale Chief Executive Officer sold 16,152 shares at an average $22.73 ($367,097)
  11. 4 Grant or award Chief Executive Officer acquired 157,895 shares (grant or award)
  12. 4 Grant or award Hindson Benjamin J. acquired 88,816 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 106,579 shares (grant or award)
  14. 4 Planned sale Director sold 7,579 shares at $19.41 ($147,108)
  15. 4 Open-market sale Chief Executive Officer sold 9,632 shares at $18.58 ($178,928)
  16. 4 Open-market sale Chief Financial Officer sold 8,968 shares at $18.58 ($166,593)
  17. 4 Open-market sale Hindson Benjamin J. sold 7,826 shares at $18.58 ($145,379)
  18. 4 Exercise or conversion Chief Executive Officer acquired 50,000 shares (option exercise)
  19. 4 Open-market sale Chief Financial Officer sold 11,888 shares at $19.00 ($225,852)
  20. 4 Open-market sale Hindson Benjamin J. sold 8,283 shares at $19.00 ($157,363)

Page 2 of 21 · 410 filings